Phosphate

Researchers have discovered a link between neurotoxicity related to chimeric antigen receptor T-cell therapy and development of subsequent hypophosphatemia.

A better understanding of chronic kidney disease may be found in the study of aging, according to a presenter at the International Conference on Dialysis.

Due to a significant association between the urine to phosphate-to-creatinine ratio and mortality among individuals without chronic kidney disease, researchers suggest this may be a predictor for future adverse events in this population.

Results of a small pilot study showed that impaired cognition was common in adults with hypothyroidism and linked to lower serum calcium levels and higher serum phosphate levels.

Phosphate binders are not the only way to lower phosphorous levels in patients on dialysis with hyperphosphatemia, according to a speaker at the virtual Annual Dialysis Conference.

  Healio spoke with Kevin Martin, MD, professor of medicine and director of the division of nephrology at Saint Louis University School of Medicine, about the challenges of managing hyperphosphatemia, prevention measures to recommend to patients at high risk for developing the condition, unmet needs in hyperphosphatemia management and more.

  Healio spoke with Kevin Martin, MD, professor of medicine and director of the division of nephrology at Saint Louis University School of Medicine, about the challenges of managing hyperphosphatemia, prevention measures to recommend to patients at high risk for developing the condition, unmet needs in hyperphosphatemia management and more.